Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Recent Developments in the Identification of Chemotherapeutics for Chagas Disease

Author(s): Jeffrey W. Lockman and Andrew D. Hamilton

Volume 12 , Issue 8 , 2005

Page: [945 - 959] Pages: 15

DOI: 10.2174/0929867053507289

Price: $65

Abstract

Chagas Disease, caused by the T. cruzi parasite, is one of the largest public health problems in the Western hemisphere. Although its spread has diminished due to vector eradication programs, effective chemotherapeutics for the disease itself remain elusive. Many efforts towards the development of antiparasitic agents active against a number of targets have been described recently in the literature. This review summarizes developments in trypanosidal agents from 2000 through 2003.

Keywords: parasitic disease, trypanosoma cruzi, autoimmunity, proinflammatory, t cells, chemotherapeutics, gycolysis, glyceraldehyde-3-phosphate dehydrogenase (gadph)


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy